Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation

被引：0
|
作者：
Gupta, Aarti [1 ]
Kumar, Lalit [1 ]
机构：
[1] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2008年 / 29卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [31] Oral Cyclic Melphalan and Dexamethasone in the Treatment of Patients with AL Amyloidosis; Ineligible for High-Dose Melphalan and Stem Cell Transplantation.
    Sanchorawala, Vaishali
    Seldin, David C.
    Sloan, John Mark
    Berk, John L.
    Skinner, Martha
    BLOOD, 2009, 114 (22) : 748 - 748
  • [32] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    V Sanchorawala
    DG Wright
    DC Seldin
    LM Dember
    K Finn
    RH Falk
    J Berk
    K Quillen
    M Skinner
    Bone Marrow Transplantation, 2001, 28 : 637 - 642
  • [33] Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation
    Reich, G
    Held, T
    Siegert, W
    Kampf, D
    Dörken, B
    Maschmeyer, G
    BONE MARROW TRANSPLANTATION, 2001, 27 (03) : 341 - 343
  • [34] Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation
    G Reich
    Th Held
    W Siegert
    D Kampf
    B Dörken
    G Maschmeyer
    Bone Marrow Transplantation, 2001, 27 : 341 - 343
  • [35] Modified high-dose melphalan and stem cell transplantation for AL amyloidosis: experience of 14 years
    Sanchorawala, V.
    Seldin, D. C.
    Quillen, K.
    Finn, K. T.
    Sloan, J. M.
    Andrea, N. T.
    Doros, G.
    Berk, J. L.
    Dember, L. M.
    Segal, A.
    Ruberg, F. L.
    Meier-Ewert, H.
    Weisman, J.
    Skinner, M.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 180 - 181
  • [36] Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study
    Sanchorawala, Vaishali
    Quillen, Karen
    Sloan, J. Mark
    Andrea, Nancy T.
    Seldin, David C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1890 - 1892
  • [37] Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 9 - 17
  • [38] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    Sanchorawala, V
    Wright, DG
    Seldin, DC
    Dember, LM
    Finn, K
    Falk, RH
    Berk, J
    Quillen, K
    Skinner, M
    BONE MARROW TRANSPLANTATION, 2001, 28 (07) : 637 - 642
  • [39] High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
    Pooja Phull
    Vaishali Sanchorawala
    Dina Brauneis
    J. Mark Sloan
    Omar K. Siddiqi
    Karen Quillen
    Shayna Sarosiek
    Bone Marrow Transplantation, 2019, 54 : 1304 - 1309
  • [40] Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis
    S Y Lee
    R S Meehan
    D C Seldin
    J M Sloan
    K Quillen
    A Shelton
    D Brauneis
    V Sanchorawala
    Bone Marrow Transplantation, 2016, 51 : 1318 - 1322
12345